In 2007, PD-L1 was first considered as a new prognostic factor for patients with pancreatic cancer, when PD-L1 was first demonstrated to be up-regulated in PDAC specimens (230, 231). The gene discussed is CD274; the disease is familial pancreatic carcinoma.